Method of manufacturing polymer-free everolimus-eluting coronary stent fabricated by electrospinning technique
US10343184B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2017 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Sep 26, 2037 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB05D2254/00
- WIPO fieldSurface technology, coating
- WIPO sectorChemistry
Abstract
Provided is a drug-eluting coronary stent. In the drug-eluting coronary stent according to the present invention, electrospinning is used, thereby making it possible to precisely control a total content of an everolimus-based drug bound thereto and form a uniform layer in spite of not using a polymer causing late thrombosis, or the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.